WeVote
Log In

Bill

Bill

SB 228

Appropriates money to establish a Pediatric Stem Cell and Bone Marrow Transplant Program. (BDR S-124)

2025 Regular Session Introduced by Fabian Doñate and 1 co-sponsor

Nevada bill allocates state funding to launch a pediatric stem cell and bone marrow transplant program, stalled in committee since February 2025.

(No further action taken.)
0
WeVote Research Nonpartisan
Bill Summary · SB 228

Legislative bill overview

SB 228 appropriates state funding to establish a new Pediatric Stem Cell and Bone Marrow Transplant Program in Nevada. The bill was introduced in the 2025 legislative session but has not advanced beyond committee referral, with no further action taken as of June 2025.

Why is this important

Pediatric stem cell and bone marrow transplants treat serious childhood diseases including leukemia, lymphoma, and certain genetic disorders. Establishing a dedicated state program could improve access to these potentially life-saving treatments for Nevada children and reduce the need for families to seek care out of state, which carries significant financial and logistical burdens.

Potential points of contention

  • Funding amount and fiscal impact: The specific appropriation amount is not detailed in available records, leaving uncertainty about the program's scope and cost to taxpayers
  • Program viability and capacity: Questions about whether Nevada has sufficient medical infrastructure, specialized staff, and patient volume to operate a cost-effective transplant program versus referring cases to established regional centers
  • Allocation of healthcare resources: Debate over whether state funds should prioritize this specialized program versus broader pediatric healthcare, preventive medicine, or other medical priorities with wider impact

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.